Jamieson Wellness, Inc. (JWEL.TO)
45.68
+0.05
(+0.11%)
CAD |
TSX |
Aug 25, 16:00
Jamieson Wellness Total Liabilities (Quarterly) : 677.34M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 677.34M |
| March 31, 2026 | 662.01M |
| December 31, 2025 | 685.52M |
| September 30, 2025 | 684.21M |
| June 30, 2025 | 658.93M |
| March 31, 2025 | 602.28M |
| December 31, 2024 | 660.41M |
| September 30, 2024 | 650.50M |
| June 30, 2024 | 645.53M |
| March 31, 2024 | 652.48M |
| December 31, 2023 | 662.38M |
| September 30, 2023 | 641.18M |
| June 30, 2023 | 689.28M |
| March 31, 2023 | 645.50M |
| December 31, 2022 | 675.67M |
| September 30, 2022 | 680.04M |
| June 30, 2022 | 310.98M |
| March 31, 2022 | 302.78M |
| December 31, 2021 | 310.45M |
| September 30, 2021 | 341.25M |
| Date | Value |
|---|---|
| June 30, 2021 | 336.61M |
| March 31, 2021 | 335.31M |
| December 31, 2020 | 316.94M |
| September 30, 2020 | 323.00M |
| June 30, 2020 | 306.18M |
| March 31, 2020 | 311.00M |
| December 31, 2019 | 302.61M |
| September 30, 2019 | 330.73M |
| June 30, 2019 | 308.24M |
| March 31, 2019 | 302.98M |
| December 31, 2018 | 308.30M |
| September 30, 2018 | 306.13M |
| June 30, 2018 | 295.38M |
| March 31, 2018 | 288.61M |
| December 31, 2017 | 291.73M |
| September 30, 2017 | 303.34M |
| June 30, 2017 | 685.62M |
| March 31, 2017 | 677.62M |
| December 31, 2016 | 556.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Leef Brands, Inc. | 77.25M |
| NeutriSci International, Inc. | -- |
| Vitality Products, Inc. | 2.29M |
| Genix Pharmaceuticals Corp. | 1.583M |
| LSL Pharma Group, Inc. | 65.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.234B |
| Shareholders Equity (Quarterly) | 509.52M |
| Debt to Equity Ratio | 0.9369 |
| Current Ratio | 3.408 |
| Net Debt Paydown Yield | -0.46% |